RENEO PHARMACEUTICALS INC (RPHM)

US75974E1038 - Common Stock

1.74  +0.01 (+0.58%)

After market: 1.79 +0.05 (+2.87%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
83.05M53.85M39.82M19.55M15.47M
Research and Development
56.61M37.71M28.17M15.94M13.10M
Selling, General, and Administrative Expenses
26.44M16.14M11.65M3.61M2.38M
Operating Income
-83.05M-53.85M-39.82M-19.55M-15.47M
Other Income/Expense
5.67M1.89M50.00K90.00K3.04M
Income Before Taxes
-77.39M-51.96M-39.77M-19.47M-12.44M
Net Income
-77.39M-51.96M-39.77M-19.47M-12.44M
EBITDA
-82.88M-53.76M-39.77M-19.51M-15.44M
 
Per Share Data
EPS Diluted Total Ops
-2.52-2.12-1.63-0.80-0.51
Non GAAP EPS
-2.53-2.12-4.86N/AN/A
 
Statistics

All data in USD

Charts